Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 1/20 | 0.67 |
| ▸ | ERN1 | O75460 | 1/20 | 0.67 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.67 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.67 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 7/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.54 |
| ▸ | BCR | P11274 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL28629154 | 0.81 | ERN1 (0.93) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL30485148 | 0.80 | ERN1 (1.00) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL11469615 | 0.80 | TLR2 (0.67) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL16004 | 0.80 | ERN1 (1.00) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL929734 | 0.80 | ERN1 (1.00) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL10054715 | 0.80 | TLR2 (0.67) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL27656312 | 0.79 | MAPT (0.51) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL7990624 | 0.79 | TLR2 (0.46) | TLR2ERN1TLR1TLR6CA12 | |
| SCHEMBL14909 | 0.79 | NFE2L2 (0.55) | CA12MAPTKDM4ELMNAALDH1A1 | |
| SCHEMBL29377009 | 0.79 | NFE2L2 (0.55) | CA12MAPTKDM4ELMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003058-A1 | NATURAL VANILLIN COMPOSITIONS | RHODIA OPERATIONS (FR) | 2022-06-01 | — | — | EP | claimed |
| US-7803846-B2 | Highly durable polymer electrolytic membrane for a fuel cell having a cross-linked structure | JAPAN ATOMIC ENERGY AGENCY (JP) | 2010-09-28 | — | — | US | claimed |
| US-20060134493-A1 | Highly durable polymer electrolytic membrane for a fuel cell having a cross-linked structure | JAPAN ATOMIC ENERGY AGENCY (JP) | 2006-06-22 | — | — | US | claimed |
| EP-4103144-B1 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-3045161-B1 | Use of active mixtures of 1,2-hexanediol and 1,2-octanediol in cosmetic, pharmaceutical or dermatological emulsions | SYMRISE AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4706780-A2 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-20070224480-A1 | Process for producing polymer electrolyte membranes for fuel cells, polymer electrolyte membranes for fuel cells produced by the process, and fuel cell membrane-electrode assemblies using the membranes | JAPAN ATOMIC ENERGY AGENCY (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070207359-A1 | Crosslinked nano-inorganic particle/polymer electrolyte membrane and method for producing same, and membrane electrode assembly using same | JAPAN ATOMIC ENERGY AGENCY (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1742286-A1 | Crosslinked polymer electrolyte fuel cell membranes and their producing process | Japan Atomic Energy Agency (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-20060281824-A1 | Crosslinked polymer electrolyte fuel cell membranes and their producing process | JAPAN ATOMIC ENERGY AGENCY (JP) | 2006-12-14 | — | — | US | disclosed |
| US-20060258714-A1 | Chromane and chromene derivatives and uses thereof | WYETH (US) | 2006-11-16 | — | — | US | disclosed |
| WO-2006116165-A1 | CHROMANE AND CHROMENE DERIVATIVES AND USES THEREOF | WYETH (US) | 2006-11-02 | — | — | WO | disclosed |
| US-20060134493-A1 | Highly durable polymer electrolytic membrane for a fuel cell having a cross-linked structure | JAPAN ATOMIC ENERGY AGENCY (JP) | 2006-06-22 | — | — | US | disclosed |
| CN-1246461-C | Method for compositions for modifying levels of secondary metabolic compounds in plants | CA NAT RESEARCH COUNCIL (CA) | 2006-03-22 | — | — | CN | disclosed |
| CN-1292822-A | Method for compositions for modifying levels of secondary metabolic compounds in plants | CA NAT RESEARCH COUNCIL (CA) | 2001-04-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060258714-A1 | Chromane and chromene derivatives and uses thereof | HTR1A, HTR2C, CHRM1 | TLR2 658/4885ERN1 3054/4885TLR1 688/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | TLR2 251/4885ERN1 3740/4885TLR1 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.